ArticleJournal of experimental & clinical cancer research : CR2023

MYC up-regulation confers vulnerability to dual inhibition of CDK12 and CDK13 in high-risk Group 3 medulloblastoma.

Consuelo Pitolli et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.